Durban — Achieving AIDS reduction targets and eventually ending the disease by 2030 is taking centre stage at the 21st International AIDS conference, underway in Durban.
The conference has seen the debate on finding an effective HIV preventative vaccine resonate among many delegates. And now it has emerged that South Africa is about to launch a ground breaking AMP study or Antibody Mediated Prevention study soon, the biggest in seven years.
...
AllAfrica Subscription Content
You must be an allAfrica.com subscriber for full access to certain content.
You have selected an article from the AllAfrica archive, which requires a subscription. You can subscribe by visiting our subscription page. Or for more information about becoming a subscriber, you can read our subscription and contribution overview.
For information about our premium subscription services:
You can also freely access - without a subscription - hundreds of today's top Africa stories and thousands of recent news articles from our home page »
Already a subscriber? Sign in for full access to article